Cargando…
Effect of COVID-19 on Stress and Biomarkers: An Exploratory Cross-Sectional Study
Background Anxiety and stress in COVID-19 lead to continual pro-inflammatory cytokine activity resulting in excessive inflammation. Levels of different bio indices of COVID-19 may predict clinical outcomes and the severity of COVID-19 disease and may correlate with anxiety and stress levels. Objecti...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066816/ https://www.ncbi.nlm.nih.gov/pubmed/37016651 http://dx.doi.org/10.7759/cureus.35702 |
_version_ | 1785018337449738240 |
---|---|
author | Kumari, Amita Itagi, Afreen Begum H Rukadikar, Charushila A D, Amudharaj Naik, Bijaya N Juhi, Ayesha Naik, Sunil Dipankar, Satish P |
author_facet | Kumari, Amita Itagi, Afreen Begum H Rukadikar, Charushila A D, Amudharaj Naik, Bijaya N Juhi, Ayesha Naik, Sunil Dipankar, Satish P |
author_sort | Kumari, Amita |
collection | PubMed |
description | Background Anxiety and stress in COVID-19 lead to continual pro-inflammatory cytokine activity resulting in excessive inflammation. Levels of different bio indices of COVID-19 may predict clinical outcomes and the severity of COVID-19 disease and may correlate with anxiety and stress levels. Objectives To measure the level of anxiety in COVID-19 patients using the coronavirus anxiety scale (CAS) as an assessment of psychological stress. To measure the levels of blood biomarkers and biochemical and hematological markers of inflammation in COVID-19. To record and measure the indices of short-term HRV in COVID-19 patients to assess their physiological and psychological stress levels. To determine the relationship between anxiety scores, levels of laboratory indices (blood biomarkers), and HRV parameters across mild, moderate and severe cases of COVID-19. Material and method A total of 300 COVID-19 patients aged between 18 and 55 years were included. A questionnaire-based CAS was used to assess anxiety levels. Short-term HRV was recorded to measure stress. Blood biomarkers: Biochemical and hemato-cytological markers of inflammation were measured. Statistical analyses were performed using the SPSS software version 20.0. Results Anxiety and stress increased with the severity of COVID-19. A positive correlation was detected between anxiety and serum ferritin, IL-6, MCV, and MCH levels, and a negative correlation between the corona anxiety score and RBC count. The increase in the severity of COVID-19 showed elevated levels of WBC count, neutrophil%, platelet count, neutrophil/lymphocyte ratio, serum ferritin, D-dimer, C-reactive protein, procalcitonin, interleukin-6, and lactate dehydrogenase, and decreased lymphocyte and monocyte percentages. The increase in the severity of COVID-19 decreased lymphocyte, monocyte, and eosinophil counts. Conclusion The Corona Anxiety Scale and heart rate variability can be used as complementary tools to index COVID-19-related anxiety and stress. An association exists between immune dysregulation and heart rate variability, which can be used to predict the inflammatory response and prognosis of COVID-19. |
format | Online Article Text |
id | pubmed-10066816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-100668162023-04-03 Effect of COVID-19 on Stress and Biomarkers: An Exploratory Cross-Sectional Study Kumari, Amita Itagi, Afreen Begum H Rukadikar, Charushila A D, Amudharaj Naik, Bijaya N Juhi, Ayesha Naik, Sunil Dipankar, Satish P Cureus Allergy/Immunology Background Anxiety and stress in COVID-19 lead to continual pro-inflammatory cytokine activity resulting in excessive inflammation. Levels of different bio indices of COVID-19 may predict clinical outcomes and the severity of COVID-19 disease and may correlate with anxiety and stress levels. Objectives To measure the level of anxiety in COVID-19 patients using the coronavirus anxiety scale (CAS) as an assessment of psychological stress. To measure the levels of blood biomarkers and biochemical and hematological markers of inflammation in COVID-19. To record and measure the indices of short-term HRV in COVID-19 patients to assess their physiological and psychological stress levels. To determine the relationship between anxiety scores, levels of laboratory indices (blood biomarkers), and HRV parameters across mild, moderate and severe cases of COVID-19. Material and method A total of 300 COVID-19 patients aged between 18 and 55 years were included. A questionnaire-based CAS was used to assess anxiety levels. Short-term HRV was recorded to measure stress. Blood biomarkers: Biochemical and hemato-cytological markers of inflammation were measured. Statistical analyses were performed using the SPSS software version 20.0. Results Anxiety and stress increased with the severity of COVID-19. A positive correlation was detected between anxiety and serum ferritin, IL-6, MCV, and MCH levels, and a negative correlation between the corona anxiety score and RBC count. The increase in the severity of COVID-19 showed elevated levels of WBC count, neutrophil%, platelet count, neutrophil/lymphocyte ratio, serum ferritin, D-dimer, C-reactive protein, procalcitonin, interleukin-6, and lactate dehydrogenase, and decreased lymphocyte and monocyte percentages. The increase in the severity of COVID-19 decreased lymphocyte, monocyte, and eosinophil counts. Conclusion The Corona Anxiety Scale and heart rate variability can be used as complementary tools to index COVID-19-related anxiety and stress. An association exists between immune dysregulation and heart rate variability, which can be used to predict the inflammatory response and prognosis of COVID-19. Cureus 2023-03-02 /pmc/articles/PMC10066816/ /pubmed/37016651 http://dx.doi.org/10.7759/cureus.35702 Text en Copyright © 2023, Kumari et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Allergy/Immunology Kumari, Amita Itagi, Afreen Begum H Rukadikar, Charushila A D, Amudharaj Naik, Bijaya N Juhi, Ayesha Naik, Sunil Dipankar, Satish P Effect of COVID-19 on Stress and Biomarkers: An Exploratory Cross-Sectional Study |
title | Effect of COVID-19 on Stress and Biomarkers: An Exploratory Cross-Sectional Study |
title_full | Effect of COVID-19 on Stress and Biomarkers: An Exploratory Cross-Sectional Study |
title_fullStr | Effect of COVID-19 on Stress and Biomarkers: An Exploratory Cross-Sectional Study |
title_full_unstemmed | Effect of COVID-19 on Stress and Biomarkers: An Exploratory Cross-Sectional Study |
title_short | Effect of COVID-19 on Stress and Biomarkers: An Exploratory Cross-Sectional Study |
title_sort | effect of covid-19 on stress and biomarkers: an exploratory cross-sectional study |
topic | Allergy/Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066816/ https://www.ncbi.nlm.nih.gov/pubmed/37016651 http://dx.doi.org/10.7759/cureus.35702 |
work_keys_str_mv | AT kumariamita effectofcovid19onstressandbiomarkersanexploratorycrosssectionalstudy AT itagiafreenbegumh effectofcovid19onstressandbiomarkersanexploratorycrosssectionalstudy AT rukadikarcharushilaa effectofcovid19onstressandbiomarkersanexploratorycrosssectionalstudy AT damudharaj effectofcovid19onstressandbiomarkersanexploratorycrosssectionalstudy AT naikbijayan effectofcovid19onstressandbiomarkersanexploratorycrosssectionalstudy AT juhiayesha effectofcovid19onstressandbiomarkersanexploratorycrosssectionalstudy AT naiksunil effectofcovid19onstressandbiomarkersanexploratorycrosssectionalstudy AT dipankarsatishp effectofcovid19onstressandbiomarkersanexploratorycrosssectionalstudy |